
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112189-112189
Open Access | Times Cited: 100
Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112189-112189
Open Access | Times Cited: 100
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
Peter M. George, Anna Reed, Sujal R. Desai, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 671
Open Access | Times Cited: 72
Peter M. George, Anna Reed, Sujal R. Desai, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 671
Open Access | Times Cited: 72
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis
Patricia Rodríguez-Morales, Ruth A. Franklin
Trends in Immunology (2023) Vol. 44, Iss. 12, pp. 986-998
Closed Access | Times Cited: 55
Patricia Rodríguez-Morales, Ruth A. Franklin
Trends in Immunology (2023) Vol. 44, Iss. 12, pp. 986-998
Closed Access | Times Cited: 55
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection
Jian Zheng, Hima Dhakal, Enya Qing, et al.
Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Jian Zheng, Hima Dhakal, Enya Qing, et al.
Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 62
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 62
SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection
Yue Qu, Aline Haas de Mello, Dorothea R. Morris, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 33
Yue Qu, Aline Haas de Mello, Dorothea R. Morris, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 33
Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2
L. Heydemann, Małgorzata Ciurkiewicz, Georg Beythien, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
L. Heydemann, Małgorzata Ciurkiewicz, Georg Beythien, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Systems analysis of innate and adaptive immunity in Long COVID
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 13
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 13
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 12
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 12
Comparative single-cell analysis reveals IFN-γ as a driver of respiratory sequelae after acute COVID-19
Chaofan Li, Wei Qian, Xiaoqin Wei, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 12
Chaofan Li, Wei Qian, Xiaoqin Wei, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 12
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
An aberrant immune–epithelial progenitor niche drives viral lung sequelae
Harish Narasimhan, In Su Cheon, Wei Qian, et al.
Nature (2024)
Closed Access | Times Cited: 10
Harish Narasimhan, In Su Cheon, Wei Qian, et al.
Nature (2024)
Closed Access | Times Cited: 10
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 9
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 9
Spatial transcriptomics: recent developments and insights in respiratory research
Wenjia Wang, Liuxi Chu, Liyong He, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Wenjia Wang, Liuxi Chu, Liyong He, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Microvascular significance of TGF-β axis activation in COVID-19
Lauren M. Arguinchona, Caterina Zagona‐Prizio, Megan E. Joyce, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 18
Lauren M. Arguinchona, Caterina Zagona‐Prizio, Megan E. Joyce, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 18
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review
Jennifer Sasson, G. Brett Moreau, William A. Petri
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 6, pp. 727-732
Open Access | Times Cited: 16
Jennifer Sasson, G. Brett Moreau, William A. Petri
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 6, pp. 727-732
Open Access | Times Cited: 16
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Anindya Roy, Lei Shi, Ashley Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Acute lung injury: a view from the perspective of necroptosis
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 5
Jinyan Dong, Weihong Liu, Wenli Liu, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 997-1018
Closed Access | Times Cited: 5
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R. Martinez, Fernando R. Moreira, Nicholas Catanzaro, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 5
David R. Martinez, Fernando R. Moreira, Nicholas Catanzaro, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 5
Recruited atypical Ly6G + macrophages license alveolar regeneration after lung injury
Cecilia Ruscitti, Joan Abinet, Pauline Maréchal, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 5
Cecilia Ruscitti, Joan Abinet, Pauline Maréchal, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 5
Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5
Animal Models of Non-Respiratory, Post-Acute Sequelae of COVID-19
Abigail Vanderheiden, Michael Diamond
Viruses (2025) Vol. 17, Iss. 1, pp. 98-98
Open Access
Abigail Vanderheiden, Michael Diamond
Viruses (2025) Vol. 17, Iss. 1, pp. 98-98
Open Access